quinupristin/dalfopristin will boost the degree or impact of lemborexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Stay clear of coadministration of lemborexant with reasonable or solid CYP3A inhibitors. This drugs may cause diarrhea, and in s